|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acrylamide |
CAS 79-06-1 | ||
CH2=CHCONH2 |
RTECS AS3325000 | ||
|
Synonyms & Trade Names Acrylamide monomer, Acrylic amide, Propenamide, 2-Propenamide |
DOT ID & Guide 2074 153P |
||
Exposure
|
NIOSH REL: Ca TWA 0.03 mg/m3 [skin] See Appendix A | ||
| OSHA PEL†: TWA 0.3 mg/m3 [skin] | |||
| IDLH Ca [60 mg/m3] See: 79061 | Conversion | ||
|
Physical Description White crystalline, odorless solid. |
|||
|
MW: 71.1 |
BP: 347-572°F (Decomposes) |
MLT: 184°F |
Sol(86°F): 216% |
|
VP: 0.007 mmHg |
IP: 9.50 eV |
|
Sp.Gr: 1.12 |
|
Fl.P: 280°F |
UEL: ? |
LEL: ? |
|
| Combustible Solid (may also be dissolved in flammable liquids). | |||
|
Incompatibilities & Reactivities Strong oxidizers [Note: May polymerize violently upon melting.] |
|||
|
Measurement Methods OSHA 21, PV2004 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin; ataxia, numb limbs, paresthesia; muscle weakness; absent deep tendon reflex; hand sweating; lassitude (weakness, exhaustion), drowsiness; reproductive effects; [potential occupational carcinogen] | |
|
Target Organs
Eyes, skin, central nervous system, peripheral nervous system, reproductive system Cancer Site [in animals: tumors of the lungs, testes, thyroid & adrenal glands] |
|
| See also: INTRODUCTION See ICSC CARD: 0091 See MEDICAL TESTS: 0007 |